Glenmark Pharmaceuticals Ltd
BSE:532296
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glenmark Pharmaceuticals Ltd
BSE:532296
|
IN |
|
M
|
Marley Spoon Group SE
F:MS1
|
LU |
|
Barrick Mining Corp
SIX:B
|
CA |
|
N
|
New Stratus Energy Inc
F:80N
|
CA |
|
M
|
Murata Manufacturing Co Ltd
XBER:MUR1
|
JP |
|
Arista Networks Inc
F:1170
|
US |
|
Mizuho Financial Group Inc
F:MZ8A
|
JP |
|
S
|
SAP SE
DUS:SAP
|
DE |
|
B
|
Bausch Health Companies Inc
F:BVF
|
CA |
|
Elica SpA
MIL:ELC
|
IT |
|
E
|
Evertec Inc
SWB:2EV
|
PR |
|
NOS SGPS SA
OTC:ZONNF
|
PT |
|
H
|
Horiba Ltd
DUS:01H
|
JP |
|
888 Holdings PLC
LSE:EVOK
|
GI |
|
J
|
JAFCO Group Co Ltd
SWB:JAF
|
JP |
Wall St Price Targets
GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 255.85 INR with a low forecast of 1 498.71 INR and a high forecast of 2 840.09 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLENMARK's stock price target?
Price Target
2 255.85
INR
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 255.85 INR with a low forecast of 1 498.71 INR and a high forecast of 2 840.09 INR.
What is the Revenue forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
38%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 38%.
